Genapsys logo — Pioneering affordable and scalable genomic sequencing to adv...

Genapsys

Pioneering affordable and scalable genomic sequencing to advance research and diagnostics with integrity and resilience.

Founded 2010 Series D Total: $319.00M Biotechnology, Health Care +2

General Information

Company Name Genapsys
Founded Year 2010
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Genapsys. To contact Genapsys, visit genapsys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genapsys compare?

A PDF of Genapsys and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genapsys soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genapsys

Genapsys is a pioneering biotechnology startup that aims to revolutionize genomic sequencing. Established in 2010 and headquartered in Redwood City, California, the company is committed to providing affordable and scalable genomic sequencing solutions. With a strong focus on integrity and resilience, Genapsys is dedicated to delivering groundbreaking sequencing technologies and exceptional service to its customers and partners. The company's last investment was a significant $70.00M Series D round on 27 May 2021, with participation from PBM Capital, Soleus Capital, and Farallon Capital Management. Genapsys operates within the realms of Biotechnology, Health Care, Life Sciences, and Clean Energy, and it aims to advance research and diagnostics with its innovative and inclusive approach to genomics.

Business keywords: Genomic Sequencing, Research, Diagnostics, Affordable Solutions, Scalable Technology, Innovation, Integrity, Resilience, Inclusivity, Biomedical Research, California Innovation

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $70.00M 3
PBM Capital, Soleus Capital +1
27 May 2021
Debt Financing $75.00M 1
Oxford Finance LLC
06 Feb 2020
Series C $90.00M 1
Foresite Capital
21 Nov 2019
Series C $32.50M 1
Casdin Capital
15 Jan 2018
Convertible Note Undisclosed -
30 Mar 2017
Series B $37.50M 2
IPV Capital, Decheng Capital
14 Nov 2013
Series A $8.50M 1
Decheng Capital
22 Mar 2013
Grant $5.50M 1
National Human Genome Research Institute
01 Sep 2012
Convertible Note Undisclosed 1
Plug and Play
18 May 2012

Genapsys Alternatives & Competitors

View All Alternatives
Genapsys vs
Pierian
Pierian United States

Genomics in Practice

Venture round
55 employees
Biotechnology, Health Care
Genapsys vs
54gene
54gene Nigeria

Equalizing Precision Medicine

112 employees
Biotechnology, Health Care
Genapsys vs

🧬Sequencing your genome is the first step in a life-changing journey | Get more info: www.veritasin...

Series A
68 employees
Biotechnology, Life Sciences

FAQ About Genapsys

Pioneering affordable and scalable genomic sequencing to advance research and diagnostics with integrity and resilience.
Genapsys was founded in 2010.
Genapsys operates in Biotechnology, Health Care, Life Sciences and Clean Energy. Its work centres on Genomic Sequencing, Research, Diagnostics and Affordable Solutions.
Genapsys has completed 9 funding rounds, raising a total of $319.00M. The latest funding stage is Series D.
Top alternatives and competitors to Genapsys include Pierian, 54gene, Veritas Intercontinental, RainDance Technologies, Roswell . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genapsys and Pierian are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genapsys, https://bouncewatch.com/company/genapsys, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes